Pretreatment prognostic nutritional index is a prognostic marker for extensive-stage small cell lung cancer patients treated with anlotinib

BACKGROUND: Anlotinib is a multi-targeted tyrosine kinase inhibitor that inhibits tumor angiogenesis which has shown activity in several malignancies and approved for the treatment of small cell lung cancer (SCLC) in China. However, there are no markers can predict the clinical outcomes of anlotinib...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:J Thorac Dis
Main Authors: Liu, Jingjing, Li, Shuang, Zhang, Shuang, Yang, Changliang, Zhang, Liang, Zhang, Bin, Cheng, Ying, Wang, Changli
Formato: Artigo
Idioma:Inglês
Publicado em: AME Publishing Company 2020
Assuntos:
Original Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC7656377/
https://ncbi.nlm.nih.gov/pubmed/33209408
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.21037/jtd-20-755
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados